247 related articles for article (PubMed ID: 24470255)
1. Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b.
Adapala NS; Barbe MF; Tsygankov AY; Lorenzo JA; Sanjay A
J Cell Biochem; 2014 Jul; 115(7):1277-89. PubMed ID: 24470255
[TBL] [Abstract][Full Text] [Related]
2. The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival.
Adapala NS; Barbe MF; Langdon WY; Nakamura MC; Tsygankov AY; Sanjay A
J Biol Chem; 2010 Nov; 285(47):36745-58. PubMed ID: 20851882
[TBL] [Abstract][Full Text] [Related]
3. Loss of Cbl-PI3K interaction in mice prevents significant bone loss following ovariectomy.
Adapala NS; Holland D; Scanlon V; Barbe MF; Langdon WY; Tsygankov AY; Lorenzo JA; Sanjay A
Bone; 2014 Oct; 67():1-9. PubMed ID: 24994594
[TBL] [Abstract][Full Text] [Related]
4. Cbl-PI3K interaction regulates Cathepsin K secretion in osteoclasts.
Yu J; Adapala NS; Doherty L; Sanjay A
Bone; 2019 Oct; 127():376-385. PubMed ID: 31299383
[TBL] [Abstract][Full Text] [Related]
5. Cbl-phosphatidylinositol 3 kinase interaction differentially regulates macrophage colony-stimulating factor-mediated osteoclast survival and cytoskeletal reorganization.
Adapala NS; Barbe MF; Langdon WY; Tsygankov AY; Sanjay A
Ann N Y Acad Sci; 2010 Mar; 1192():376-84. PubMed ID: 20392263
[TBL] [Abstract][Full Text] [Related]
6. Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia.
Nakajima A; Sanjay A; Chiusaroli R; Adapala NS; Neff L; Itzsteink C; Horne WC; Baron R
J Bone Miner Res; 2009 Jul; 24(7):1162-72. PubMed ID: 19257814
[TBL] [Abstract][Full Text] [Related]
7. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of Cbl-PI3K interaction increases bone formation and osteoblast proliferation.
Brennan T; Adapala NS; Barbe MF; Yingling V; Sanjay A
Calcif Tissue Int; 2011 Nov; 89(5):396-410. PubMed ID: 21952831
[TBL] [Abstract][Full Text] [Related]
9. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N
J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868
[TBL] [Abstract][Full Text] [Related]
10. Loss of Cbl-PI3K interaction modulates the periosteal response to fracture by enhancing osteogenic commitment and differentiation.
Scanlon V; Walia B; Yu J; Hansen M; Drissi H; Maye P; Sanjay A
Bone; 2017 Feb; 95():124-135. PubMed ID: 27884787
[TBL] [Abstract][Full Text] [Related]
11. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
[TBL] [Abstract][Full Text] [Related]
12. Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions.
Yang FC; Chen S; Robling AG; Yu X; Nebesio TD; Yan J; Morgan T; Li X; Yuan J; Hock J; Ingram DA; Clapp DW
J Clin Invest; 2006 Nov; 116(11):2880-91. PubMed ID: 17053831
[TBL] [Abstract][Full Text] [Related]
13. CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1.
Belizaire R; Koochaki SHJ; Udeshi ND; Vedder A; Sun L; Svinkina T; Hartigan C; McConkey M; Kovalcik V; Bizuayehu A; Stanclift C; Schenone M; Carr SA; Padron E; Ebert BL
Blood; 2021 Apr; 137(16):2209-2220. PubMed ID: 33512474
[TBL] [Abstract][Full Text] [Related]
14. 2-(trimethylammonium) ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate suppresses osteoclast maturation and bone resorption by targeting macrophage-colony stimulating factor signaling.
Park SJ; Park DR; Bhattarai D; Lee K; Kim J; Bae YS; Lee SY
Mol Cells; 2014 Aug; 37(8):628-35. PubMed ID: 25139265
[TBL] [Abstract][Full Text] [Related]
15. Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade.
Moon JB; Kim JH; Kim K; Youn BU; Ko A; Lee SY; Kim N
J Immunol; 2012 Jan; 188(1):163-9. PubMed ID: 22131333
[TBL] [Abstract][Full Text] [Related]
16. Role of Cbl-PI3K Interaction during Skeletal Remodeling in a Murine Model of Bone Repair.
Scanlon V; Soung do Y; Adapala NS; Morgan E; Hansen MF; Drissi H; Sanjay A
PLoS One; 2015; 10(9):e0138194. PubMed ID: 26393915
[TBL] [Abstract][Full Text] [Related]
17. Effects of isoform-selective phosphatidylinositol 3-kinase inhibitors on osteoclasts: actions on cytoskeletal organization, survival, and resorption.
Shugg RP; Thomson A; Tanabe N; Kashishian A; Steiner BH; Puri KD; Pereverzev A; Lannutti BJ; Jirik FR; Dixon SJ; Sims SM
J Biol Chem; 2013 Dec; 288(49):35346-57. PubMed ID: 24133210
[TBL] [Abstract][Full Text] [Related]
18. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
[TBL] [Abstract][Full Text] [Related]
19. A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activation.
Arron JR; Vologodskaia M; Wong BR; Naramura M; Kim N; Gu H; Choi Y
J Biol Chem; 2001 Aug; 276(32):30011-7. PubMed ID: 11406619
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity.
Congleton J; Shen M; MacDonald R; Malavasi F; Yen A
Cell Signal; 2014 Jul; 26(7):1589-97. PubMed ID: 24686085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
